1-[(BENZYLOXY)-METHYL]-5-ISOPROPYL-6-(1-NAPHTHYLMETHYL)-URACIL
Compound with spectra: 1 NMR, and 1 MS (GC)
![1-[(BENZYLOXY)-METHYL]-5-ISOPROPYL-6-(1-NAPHTHYLMETHYL)-URACIL](/api/compound/LhTkkmjrDxw.png?ph=true&h=300&w=458 "1-[(BENZYLOXY)-METHYL]-5-ISOPROPYL-6-(1-NAPHTHYLMETHYL)-URACIL")
| SpectraBase Compound ID | LhTkkmjrDxw |
|---|---|
| InChI | InChI=1S/C26H26N2O3/c1-18(2)24-23(15-21-13-8-12-20-11-6-7-14-22(20)21)28(26(30)27-25(24)29)17-31-16-19-9-4-3-5-10-19/h3-14,18H,15-17H2,1-2H3,(H,27,29,30) |
| InChIKey | BYXMFGWRRQLEPK-UHFFFAOYSA-N |
| Mol Weight | 414.51 g/mol |
| Molecular Formula | C26H26N2O3 |
| Exact Mass | 414.194343 g/mol |
| Copyright | Copyright © 2020-2024 John Wiley & Sons, Inc. All Rights Reserved. |
|---|---|
| Source of Spectrum | E2-51-785-8 |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
- 1-(benzoxymethyl)-5-isopropyl-6-(1-naphthylmethyl)pyrimidine-2,4-quinone
1-ETHOXYMETHYL-5-ISOPROPYL-6-(1-NAPHTHYLMETHYL)-URACIL
1-[(2-HYDROXYETHOXY)-METHYL]-5-ISOPROPYL-6-(1-NAPHTHYLMETHYL)-URACIL
1-[(BENZYLOXY)-METHYL]-5-ETHYL-6-(1-NAPHTHYLMETHYL)-URACIL
1-(benzoxymethyl)-6-(1-naphthylmethyl)-5-propyl-pyrimidine-2,4-quinone
5-ETHYL-1-(2-METHYALLYLOXYMETHYL)-6-(NAPHTHALEN-1-YLMETHYL)-URACIL
1-[(2-HYDROXYETHOXY)-METHYL]-5-N-PROPYL-6-(1-NAPHTHYLMETHYL)-URACIL
1-ETHOXYMETHYL-5-N-PROPYL-6-(1-NAPHTHYLMETHYL)-URACIL
1-[1'-Hydroxyethoxy)methyl]-5-isopropyl-6-(.beta.-naphthalene)-uracil
1-METHOXYMETHYL-3-METHOXYMETHYL-5-METHYL-6-(1-NAPHTHYLMETHYL)-URACIL
5-(1-METHOXY-2-JODOETHYL)-3',5'-DI-O-ACETYL-2'-DEOXYURIDINE;DIASTEREOMER-#1
| Title | Journal or Book | Year |
|---|---|---|
| Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors: Part I. Synthesis and Structure-Activity Relationship of 1-Alkoxymethyl-5-alkyl-6-naphthylmethyl Uracils as HEPT Analogues | Chemical and Pharmaceutical Bulletin | 2003 |